← Back to Pharmaceutical Microbiology

Unit 2: Antimicrobial Agents

B.Sc. 3rd Year • Pharmaceutical Microbiology

Unit Weight: 15 Hours

Study Focus: This is a major examination unit. Study the definition and classification of antimicrobial agents first, followed by sources, targets, mechanisms of action, important examples and drug combinations. For long answers, always connect the drug class → target → mechanism → examples.

2.1 Introduction to Antimicrobial Agents

Antimicrobial agents are substances that inhibit the growth of microorganisms or destroy them. They are used to prevent and treat infectious diseases and may act against bacteria, fungi, viruses or parasites.

The term antimicrobial is broad. An antimicrobial agent may be antibacterial, antifungal, antiviral or antiparasitic, depending on the type of microorganism against which it acts.

Definition: An antimicrobial agent is a chemical or biological substance that kills microorganisms or inhibits their growth and multiplication.

Antimicrobial therapy works because microorganisms possess structures or metabolic processes that can be selectively targeted. The ideal antimicrobial agent should damage the microorganism while causing minimal harm to the host.

Antimicrobial Agent → Specific Microbial Target → Cellular Damage / Inhibition → Growth Inhibition or Death

2.2 Sources of Antimicrobial Agents

Antimicrobial agents may be obtained from natural sources, produced by chemical synthesis or developed using semi-synthetic and modern biotechnology approaches.

1. Natural Sources

Many antimicrobial substances were originally obtained from microorganisms. Certain microorganisms produce compounds that inhibit competing organisms in their environment.

Examples include:

2. Synthetic Sources

Some antimicrobial agents are produced completely by chemical synthesis. Synthetic chemistry allows modification of molecular structures and development of compounds with desired properties.

3. Semi-Synthetic Sources

A natural antimicrobial compound may be chemically modified to improve its stability, spectrum of activity, absorption or resistance to microbial enzymes. Such compounds are called semi-synthetic agents.

4. Biotechnology-Based Production

Modern pharmaceutical biotechnology uses microbial fermentation, recombinant DNA technology and genetic engineering to improve production of antimicrobial substances and other therapeutic products.

Source Description Example
Natural Obtained from biological sources Penicillin
Synthetic Produced through chemical synthesis Many fully synthetic antibacterial drugs
Semi-synthetic Natural molecule chemically modified Amoxicillin
Biotechnological Produced or improved using biological production systems Fermentation-derived antimicrobial products

2.3 Classification of Antimicrobial Agents

Antimicrobial agents can be classified in several ways, including according to the target microorganism, mechanism of action, chemical structure and source.

A. According to Target Organism

Antibacterial Agents

Act against bacteria. Examples include penicillins, cephalosporins, tetracyclines and macrolides.

Antifungal Agents

Act against fungi. Examples include azoles, polyenes and echinocandins.

Antiviral Agents

Act against viruses by interfering with specific stages of the viral life cycle.

Antiparasitic Agents

Act against protozoa or helminths through specific biochemical or physiological targets.

B. According to Effect

Antimicrobial agents may be described as microbicidal when they kill microorganisms or microbiostatic when they primarily inhibit microbial growth.

Term Meaning Example / Concept
Microbicidal Kills microorganisms Bactericidal action
Microbiostatic Inhibits microbial growth Bacteriostatic action

C. According to Mechanism of Action

  1. Inhibition of cell wall synthesis
  2. Damage to cell membrane
  3. Inhibition of protein synthesis
  4. Inhibition of nucleic acid synthesis
  5. Inhibition of essential metabolic pathways
  6. Interference with specific viral or parasitic processes

2.4 Major Targets of Antimicrobial Agents

Selective toxicity is an important principle of antimicrobial therapy. A drug should preferably target a microbial structure or pathway that is absent from or sufficiently different in the host.

Cell Wall + Cell Membrane + Ribosome + DNA/RNA + Metabolic Pathways → Antimicrobial Effect
Target Effect of Drug Examples
Cell wall synthesis Weakening of bacterial cell wall β-lactams, glycopeptides
Cell membrane Altered permeability and leakage Polymyxins, polyenes
30S ribosomal subunit Interference with translation Aminoglycosides, tetracyclines
50S ribosomal subunit Interference with protein synthesis Macrolides, lincosamides
DNA synthesis Inhibition of replication or damage Fluoroquinolones
RNA synthesis Inhibition of transcription Rifamycins
Folate pathway Blocks nucleotide precursor synthesis Sulfonamides, trimethoprim

2.5 Antibacterial Agents

Antibacterial agents are antimicrobial substances that act against bacteria. They may inhibit bacterial growth or kill bacterial cells. Their effectiveness depends on the susceptibility of the organism, drug concentration, site of infection and other pharmacological factors.

Major Antibacterial Drug Groups

Class Major Target Representative Examples
β-lactams Peptidoglycan cross-linking Penicillin, amoxicillin, ceftriaxone
Glycopeptides Cell wall synthesis Vancomycin
Aminoglycosides 30S ribosomal subunit Gentamicin, amikacin
Tetracyclines 30S ribosomal subunit Tetracycline, doxycycline
Macrolides 50S ribosomal subunit Erythromycin, azithromycin
Fluoroquinolones DNA gyrase / topoisomerases Ciprofloxacin, levofloxacin
Rifamycins RNA polymerase Rifampicin
Folate antagonists Folate synthesis pathway Sulfamethoxazole, trimethoprim

2.6 β-Lactam Antibiotics

β-lactam antibiotics are an important group of antibacterial agents characterized by the presence of a β-lactam ring. The group includes penicillins, cephalosporins and several other related classes.

Basic structural feature: The β-lactam ring is the characteristic structural component responsible for interaction with bacterial cell-wall synthesis enzymes.
β-LACTAM CORE O / \ C N || | C---C The exact ring system differs among penicillins, cephalosporins and other β-lactam groups.

Mechanism of Action

Bacterial cell walls contain peptidoglycan, which provides mechanical strength. The final stages of peptidoglycan synthesis involve enzymes known as penicillin-binding proteins (PBPs), including transpeptidases.

β-lactam antibiotics bind to susceptible PBPs and interfere with peptidoglycan cross-linking. As a result, the cell wall becomes structurally weak. In actively growing bacteria, this can lead to cell lysis and death.

Mechanism:
β-Lactam enters bacterial environment → Binds PBP → Inhibits Transpeptidation → Reduced Peptidoglycan Cross-linking → Weak Cell Wall → Cell Lysis

Examples

Mechanisms of Resistance

2.7 Glycopeptide Antibiotics

Glycopeptides interfere with bacterial cell-wall synthesis through a mechanism different from β-lactams. Vancomycin is the major representative example.

Mechanism

Vancomycin binds to the D-alanyl-D-alanine terminus of peptidoglycan precursors. This prevents access of enzymes required for proper cell-wall assembly.

Vancomycin → Binds D-Ala-D-Ala → Blocks Cell Wall Assembly → Cell Wall Weakening → Bacterial Death
Exam point: β-lactams primarily act on PBPs, whereas vancomycin binds the D-Ala-D-Ala terminus of peptidoglycan precursors.

2.8 Aminoglycosides

Aminoglycosides are antibacterial agents that primarily interfere with bacterial protein synthesis by acting on the 30S ribosomal subunit.

Examples

Mechanism of Action

Aminoglycosides bind to the bacterial 30S ribosomal subunit and interfere with accurate translation of mRNA. This can lead to production of abnormal proteins and disruption of cellular function.

Aminoglycoside → 30S Ribosome → Misreading of mRNA → Abnormal Proteins → Cell Damage

2.9 Tetracyclines

Tetracyclines are broad-spectrum antibacterial agents that primarily inhibit bacterial protein synthesis.

Examples

Mechanism

Tetracyclines bind to the bacterial 30S ribosomal subunit and interfere with attachment of aminoacyl-tRNA to the ribosomal acceptor site. Protein synthesis is consequently inhibited.

Tetracycline → 30S Ribosome → Blocks Aminoacyl-tRNA Attachment → Protein Synthesis Inhibited

2.10 Macrolides

Macrolides are antibacterial agents characterized by a large macrocyclic lactone ring. They primarily act on the bacterial 50S ribosomal subunit.

Examples

Mechanism

Macrolides bind to the 50S ribosomal subunit and interfere with bacterial protein synthesis, particularly movement of the growing peptide chain through the ribosome.

Macrolide → 50S Ribosome → Translation Interference → Protein Synthesis Inhibited

2.11 Fluoroquinolones

Fluoroquinolones are synthetic antibacterial agents that interfere with bacterial DNA replication.

Examples

Mechanism

Bacterial DNA replication requires enzymes such as DNA gyrase and topoisomerase IV. Fluoroquinolones interfere with these enzymes, resulting in disruption of DNA replication and chromosome processing.

Fluoroquinolone → DNA Gyrase / Topoisomerase → DNA Replication Disrupted → Bacterial Death

2.12 Rifamycins

Rifamycins inhibit bacterial RNA synthesis. Rifampicin is a major representative drug.

Mechanism

Rifampicin binds to the bacterial DNA-dependent RNA polymerase and interferes with transcription. Without proper RNA synthesis, the bacterium cannot produce proteins required for growth and survival.

Rifampicin → RNA Polymerase → Transcription Inhibited → Reduced Protein Production

2.13 Antimetabolites and Folate Pathway Inhibitors

Many microorganisms require folate derivatives for synthesis of nucleotides and other cellular components. Humans obtain folate primarily through the diet, whereas many bacteria synthesize folate using their own metabolic pathways.

Sulfonamides

Sulfonamides resemble para-aminobenzoic acid (PABA), a substrate used in bacterial folate synthesis. They competitively interfere with an early step in this pathway.

Trimethoprim

Trimethoprim inhibits bacterial dihydrofolate reductase, acting at a later step in folate metabolism.

Sulfonamide → DHPS Inhibition → Reduced Folate Formation
↓
Trimethoprim → DHFR Inhibition → Further Folate Block
Combination concept: Sulfamethoxazole and trimethoprim act sequentially at different steps of the bacterial folate pathway and are commonly used together as co-trimoxazole.

2.14 Antiviral Agents

Viruses are fundamentally different from bacteria because they depend heavily on host-cell machinery for replication. Therefore, antiviral drugs generally target specific viral proteins or stages of the viral life cycle.

Major Stages Targeted by Antiviral Drugs

Attachment → Entry / Fusion → Uncoating → Nucleic Acid Replication → Protein Processing → Assembly → Release

1. Entry and Fusion Inhibitors

These drugs interfere with attachment, entry or fusion of viruses with host cells.

2. Nucleic Acid Polymerase Inhibitors

These drugs interfere with viral DNA or RNA synthesis. Examples include nucleotide or nucleoside analogues used against selected viral infections.

3. Reverse Transcriptase Inhibitors

Retroviruses such as HIV use reverse transcriptase to convert viral RNA into DNA. Drugs targeting this enzyme interfere with viral replication.

4. Protease Inhibitors

Some viruses require proteases to process viral polyproteins into functional proteins. Protease inhibitors interfere with this maturation process.

5. Release Inhibitors

Some antiviral drugs interfere with release of newly formed viral particles from infected cells.

Antiviral Target Mechanism Example
Viral polymerase Inhibits viral nucleic acid synthesis Selected nucleoside/nucleotide analogues
Reverse transcriptase Blocks conversion of viral RNA to DNA Antiretroviral drugs
Protease Prevents processing of viral proteins Protease inhibitors
Viral entry/fusion Prevents entry into host cells Entry/fusion inhibitors

2.15 Antifungal Agents

Fungi are eukaryotic organisms and therefore share many cellular features with human cells. This makes selective toxicity more challenging than in bacterial infections.

Important antifungal targets include the fungal cell membrane, particularly ergosterol, and the fungal cell wall.

Major Antifungal Groups

Class Target / Mechanism Examples
Polyenes Bind ergosterol and disrupt fungal membrane Amphotericin B, nystatin
Azoles Inhibit ergosterol synthesis Fluconazole, itraconazole
Echinocandins Inhibit β-(1,3)-D-glucan synthesis Caspofungin

Polyenes

Polyenes such as amphotericin B interact with ergosterol in the fungal cell membrane. This alters membrane integrity and can produce leakage of intracellular components.

Amphotericin B → Ergosterol Binding → Membrane Disruption → Leakage → Fungal Cell Damage

Azoles

Azole drugs interfere with enzymes involved in ergosterol synthesis. Reduced ergosterol production affects fungal membrane structure and function.

Echinocandins

Echinocandins inhibit synthesis of β-(1,3)-D-glucan, an important component of the fungal cell wall.

2.16 Antiparasitic Agents

Antiparasitic drugs are used against parasites, including protozoa and helminths. Their mechanisms vary considerably because parasites differ in their biology and life cycles.

Antiprotozoal Agents

These drugs act against protozoan parasites. Depending on the drug, targets may include nucleic acid metabolism, cellular redox systems, protein synthesis or other parasite-specific processes.

Anthelmintic Agents

Anthelmintic drugs act against parasitic worms. Important mechanisms include interference with neuromuscular function, microtubules, energy metabolism or other essential parasite processes.

Group Target / General Action Examples
Antiprotozoal Interferes with essential protozoal metabolic or genetic processes Metronidazole, selected antimalarial agents
Benzimidazoles Interfere with parasite microtubules Albendazole, mebendazole
Macrocyclic lactones Disrupt parasite neuromuscular function Ivermectin

2.17 Antimicrobial Drugs in Combination

Sometimes two or more antimicrobial agents are used together. Combination therapy may be selected to broaden antimicrobial coverage, produce enhanced activity, prevent resistance or treat infections where more than one organism or target is involved.

Major Reasons for Combination Therapy

  1. Broadening of antimicrobial coverage: Two drugs may cover a wider range of organisms than either drug alone.
  2. Synergistic activity: The combined effect can be greater than expected from the individual agents.
  3. Sequential pathway inhibition: Two drugs may block different steps of the same metabolic pathway.
  4. Prevention of resistance: In selected infections, using multiple active agents can reduce the probability that resistant organisms will survive and dominate.
  5. Polymicrobial infection: Different organisms may require different antimicrobial agents.

Types of Drug Interaction

Interaction Meaning
Synergism Combined effect is greater than the expected effect of the individual drugs.
Additive effect Combined effect is approximately the sum of individual effects.
Antagonism One drug reduces or interferes with the activity of another.

Example: Sequential Folate Blockade

Sulfonamides inhibit an early step in bacterial folate synthesis, while trimethoprim inhibits a later step. Their combined action produces sequential blockade of the same pathway.

PABA → Dihydropteroate → Dihydrofolate → Tetrahydrofolate
Drug targets:

Sulfonamides → inhibit dihydropteroate synthase

Trimethoprim → inhibits dihydrofolate reductase

Exam point: When writing combination therapy answers, do not simply name two drugs. Explain why they are combined and how their targets interact.

2.18 Selective Toxicity

Selective toxicity means that an antimicrobial drug should preferably harm the microorganism without producing unacceptable damage to the host.

This principle is possible because microorganisms possess structures and biochemical pathways that differ from human cells. Bacterial peptidoglycan is an excellent example because human cells do not possess a peptidoglycan cell wall.

Microbial Target Reason for Selectivity
Peptidoglycan cell wall Absent in human cells
Bacterial ribosome Structurally different from human cytoplasmic ribosomes
Fungal ergosterol Different membrane sterol from the major human membrane sterol
Viral enzymes Some viral proteins are unique to the virus
Parasite-specific pathways Some pathways differ sufficiently from host pathways

2.19 Bacteriostatic and Bactericidal Agents

Antibacterial agents are sometimes classified according to whether they primarily inhibit bacterial multiplication or directly kill bacterial cells.

Feature Bacteriostatic Bactericidal
Primary effect Inhibits bacterial growth Kills bacteria
Population Stops or slows multiplication Viable bacterial population decreases
Examples Tetracyclines, macrolides Many β-lactams, aminoglycosides
Note: The bacteriostatic or bactericidal behavior of an antimicrobial can depend on the organism, drug concentration and experimental conditions. Therefore, the distinction is useful but should not be treated as completely absolute in every situation.

2.20 Summary of Major Antimicrobial Mechanisms

Target Major Mechanism Representative Drugs
Cell wall Blocks peptidoglycan synthesis Penicillins, cephalosporins, vancomycin
Cell membrane Disrupts membrane integrity Polymyxins, amphotericin B
30S ribosome Interferes with translation Aminoglycosides, tetracyclines
50S ribosome Interferes with protein synthesis Macrolides
DNA Blocks replication or damages DNA Fluoroquinolones
RNA polymerase Blocks transcription Rifampicin
Folate pathway Blocks folate synthesis Sulfonamides, trimethoprim
Fungal ergosterol Disrupts or inhibits membrane sterol Polyenes, azoles
Fungal cell wall Blocks β-glucan synthesis Echinocandins
Viral enzymes Interferes with replication or maturation Polymerase/protease inhibitors

10-Mark Long Answer Preparation

Discuss antimicrobial agents with their classification, targets, mechanisms of action and examples.

Suggested Answer Structure

  1. Define antimicrobial agents.
  2. Explain their major sources.
  3. Classify them into antibacterial, antiviral, antifungal and antiparasitic agents.
  4. Explain selective toxicity.
  5. Discuss major microbial targets: cell wall, cell membrane, ribosome, nucleic acids and metabolic pathways.
  6. Explain major antibacterial groups with examples.
  7. Describe antiviral mechanisms.
  8. Describe antifungal mechanisms.
  9. Describe antiparasitic agents.
  10. Explain antimicrobial combinations and synergism.
  11. Conclude with the importance of rational antimicrobial use.

Other Important 10-Mark Questions

  • Explain the different mechanisms of action of antibacterial agents with suitable examples.
  • Discuss antibiotics according to their microbial targets and mechanisms of action.
  • Describe antiviral, antifungal and antiparasitic agents with examples.
  • Discuss antimicrobial drugs used in combination and explain synergism, additive action and antagonism.
  • Explain the mechanism of action of antimicrobial agents acting on the bacterial cell wall, ribosome, nucleic acids and metabolic pathways.

5-Mark Preparation

2-Mark Preparation

Question Key Answer
Define antimicrobial agent. A substance that kills microorganisms or inhibits their growth.
What is selective toxicity? The ability of an antimicrobial drug to act preferentially against a microorganism while causing less harm to the host.
Name two β-lactam antibiotics. Penicillin and amoxicillin.
Name two aminoglycosides. Gentamicin and amikacin.
Name two macrolides. Erythromycin and azithromycin.
What is the target of fluoroquinolones? Bacterial DNA gyrase and/or topoisomerase IV.
Name two antifungal agents. Amphotericin B and fluconazole.
What is synergism? An interaction in which the combined antimicrobial effect is greater than expected from the individual agents.
What is a bacteriostatic agent? An agent that primarily inhibits bacterial growth and multiplication.
What is a bactericidal agent? An agent that kills bacterial cells.
Name two antiviral targets. Viral polymerase and viral protease.
Name two antiparasitic agents. Albendazole and ivermectin.

Quick Revision

Cell Wall → Membrane → Ribosome → DNA/RNA → Metabolic Pathways

Must Remember

β-lactams → PBPs Vancomycin → D-Ala-D-Ala Aminoglycosides → 30S Tetracyclines → 30S Macrolides → 50S Fluoroquinolones → DNA gyrase/topoisomerase Rifampicin → RNA polymerase Sulfonamides → DHPS Trimethoprim → DHFR Polyenes → Ergosterol Azoles → Ergosterol synthesis Echinocandins → β-glucan

Basic Mechanism Map

Important Examination Questions

Very Important Long Questions

  1. Discuss antimicrobial agents with their classification, mechanisms of action and examples.
  2. Explain the different mechanisms of action of antibacterial antibiotics with suitable examples.
  3. Discuss antiviral, antifungal and antiparasitic drugs with their targets and mechanisms of action.
  4. Explain antimicrobial combination therapy and discuss synergism, additive action and antagonism.

Important Short Questions

  1. Define selective toxicity.
  2. Write the sources of antimicrobial agents.
  3. Explain β-lactam antibiotics.
  4. Write the mechanism of action of aminoglycosides.
  5. Write the mechanism of action of tetracyclines.
  6. Explain the mechanism of action of macrolides.
  7. Write a note on fluoroquinolones.
  8. Explain antifungal agents.
  9. Explain antiviral agents.
  10. What is combination therapy?

Important Exam Points

  • Always write target + mechanism + examples when explaining an antimicrobial class.
  • β-lactams interfere with bacterial peptidoglycan cross-linking.
  • Aminoglycosides and tetracyclines primarily act on the 30S ribosomal subunit.
  • Macrolides primarily act on the 50S ribosomal subunit.
  • Fluoroquinolones interfere with bacterial DNA replication.
  • Rifampicin interferes with RNA synthesis.
  • Sulfonamides and trimethoprim interfere with the bacterial folate pathway.
  • Polyenes and azoles target the fungal membrane/ergosterol system.
  • Echinocandins inhibit fungal β-(1,3)-D-glucan synthesis.
  • Antiviral drugs generally target specific stages or enzymes of the viral life cycle.
  • Combination therapy may be used for broader coverage, synergistic activity, sequential pathway blockade or resistance-management strategies in appropriate settings.